Sterling Investment Counsel’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
9,013
+205
+2% +$27K 0.27% 63
2026
Q1
$1.23M Buy
8,808
+2,210
+33% +$309K 0.34% 55
2025
Q4
$810K Buy
6,598
+65
+1% +$7.9K 0.23% 68
2025
Q3
$725K Buy
+6,533
New +$743K 0.23% 73
2025
Q2
Sell
-6,860
Closed -$769K 148
2025
Q1
$769K Buy
+6,860
New +$708K 0.26% 66
2024
Q4
Sell
-6,842
Closed -$574K 143
2024
Q3
$574K Buy
6,842
+494
+8% +$37.7K 0.2% 77
2024
Q2
$436K Buy
6,348
+1,601
+34% +$107K 0.17% 84
2024
Q1
$348K Sell
4,747
-1,348
-22% -$104K 0.16% 108
2023
Q4
$494K Buy
6,095
+534
+10% +$41.6K 0.25% 74
2023
Q3
$417K Buy
5,561
+2,900
+109% +$223K 0.24% 79
2023
Q2
$205K Buy
2,661
+183
+7% +$14.6K 0.11% 148
2023
Q1
$206K Sell
2,478
-560
-18% -$46.4K 0.12% 146
2022
Q4
$261K Buy
+3,038
New +$241K 0.16% 131

Other funds holding GILD

Sterling Investment Counsel's GILD Position: Q2 2026 in Review

Sterling Investment Counsel increased its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, buying an estimated $27K and bringing the position to 9,013 shares worth $1.14M. The position accounts for 0.27% of the portfolio, ranked #63.

Sterling Investment Counsel first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. The position peaked at $1.23M in Q1 2026. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sterling Investment Counsel held 9,013 shares of Gilead Sciences worth $1.14M as of Q2 2026.
  • Sterling Investment Counsel bought 205 Gilead Sciences shares in Q2 2026, an estimated $27K.
  • Gilead Sciences made up 0.27% of Sterling Investment Counsel's portfolio in Q2 2026, its #63 holding.
  • Sterling Investment Counsel first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • Sterling Investment Counsel's Gilead Sciences position peaked at $1.23M in Q1 2026.
  • 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sterling Investment Counsel's 13F filing for Q2 2026, filed 20 Jul 2026.